Martin Gajdošík1, Karl Landheer1, Kelley M. Swanberg1, Lawrence S. Kegeles2,3,4, Dikoma C. Shungu5, Camilo de la Fuente-Sandoval6,7, and Christoph Juchem1,4
1Department of Biomedical Engineering, Columbia University, New York City, NY, United States, 2Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York City, NY, United States, 3New York State Psychiatric Institute, New York City, NY, United States, 4Department of Radiology, Columbia University Medical Center, New York City, NY, United States, 5Weill Cornell Medicine, New York City, NY, United States, 6Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico, 7Department of Neuropsychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico
Synopsis
Point resolved spectroscopy sequence (PRESS) is the most commonly used sequence for in vivo magnetic resonance spectroscopy. While implemented by all major vendors, implementation details like timings, durations and shapes of the RF pulses differ among them. Here, we investigate the impact that inappropriate basis information can have on MRS metabolite quantification with linear combination modeling for quantification.
Introduction
Point
resolved spectroscopy sequence (PRESS)1 is the most
commonly used sequence for in vivo magnetic resonance spectroscopy. While implemented by all
major vendors (i.e., Siemens, Philips and General Electric (GE)), implementation
details like exact timings, durations and shapes of the RF pulses differ among them2,3. Thus, a PRESS
acquisition with echo time (TE) of 35 ms from one vendor may be similar but not
identical to that from another. Here, we investigate the impact that inappropriate
basis information can have on MRS metabolite quantification with linear combination modeling software.
Methods
Subjects
& Scanners Spectra
from 100 subjects obtained at the National Institute of Neurology and
Neurosurgery in Mexico City were analyzed retrospectively. Of the 100 spectra, 50
were recorded with a Siemens Skyra 3 T (Siemens Healthineers, Erlangen, Germany)
with a 20-channel head coil (Siemens) in medial prefrontal cortex, and the other 50 with a GE Signa Excite HDxt 3 T (GE Healthcare, Waukesha, WI) with an 8-channel head
coil (GE) in the right dorsal caudate nucleus (5).
MRS
Sequence All
brain spectra were measured with the vendors’ standard product PRESS sequence
with T
E/T
R 35/2000 ms, and:
- GE: volume of interest (VOI) = 2.0x2.0x2.0
cm3 (8 mL), number of excitations (NEX) = 128, bandwidth (BW) = 5000
Hz, number of points = 4096.
- Siemens: VOI = 3.0x2.5x2.5 cm3
(19 mL), NEX = 128, BW = 2500 Hz, number of points = 4096.
The recorded spectra were fitted with the matched basis set using the correct timings, durations and shape of RF pulses, a basis set generated with the matched timings and durations, but with the hard-pulse approximation, as well as basis sets corresponding to the PRESS implementations of the same T
E from the two other vendors.
Simulation
of basis sets Basis
sets comprising 18 metabolites (Fig. 1A), Asc, Asp, Cho, Cr, GABA, GPC, GSH,
Glc, Gln, Glu, Gly, Lac, NAA, NAAG, PE, Tau, mI, and sI, were simulated with 128
3
spatial points in MAgnetic Resonance Spectrum Simulator (MARSS)
2,3. The
hard-pulse basis sets were generated using experimental details specific to the particular vendor (i.e., Siemens for Siemens data or GE for GE data), but used
only a single spatial point thereby not modeling the spatial transition bands
of the RF pulses.
Analysis Experimental
spectra were processed with INSPECTOR
6–9 and analyzed with
LCModel
4 (version 6.3-1P).
Each spectrum was fitted with four different basis sets using standard .CONTROL
parameters.
- GE spectra: matched GE, GE with hard
pulses, Philips and Siemens.
- Siemens spectra: matched Siemens, Siemens
with hard pulses, Philips and GE.
True
metabolite concentrations encountered
in
vivo cannot be measured, thus the analysis focused on apparent
concentration differences between the reference fit, which was obtained with
the matched basis set, e.g. matched GE basis set for spectrum acquired with GE
sequence, and the fit outcomes considering the three other conditions, i.e. GE
hard pulse, Siemens, and Philips. The differences were calculated as errors
relative to the matched basis fits (in percent). Median, mean, standard deviation
(SD) of percent errors and number of undefined numbers due to metabolite
concentrations of zero in the reference fit (# NaN) were determined for all
spectral analyses.
Results & Discussion
Spectral quality from all
subjects measured with two different scanners is illustrated in Figure 1B &
C. Illustrations of fitting an experimental PRESS spectrum with LCModel using
different basis sets are depicted in Figure 2 for GE, and in Figure 3 for
Siemens. The percent errors of all metabolites for GE are summarized in Table 1 and for Siemens spectra inTable 2. The mean percent errors of larger
signals (e,g, NAA+NAAG, Cr) were < 5%,
but in case of GPC+Cho the relative error was up to 12.6% (Table 2). In case of
Glu+Gln, using the GE basis set for linear combination modeling of Siemens data
resulted in a 19.1% error (Table 2). Smaller signals like GSH showed mean errors
up to 43% (Table 2). Especially low-concentrated metabolites were highly
susceptible to minute differences in basis sets (e.g. Asp in Table 1). Though spectra measured on the Siemens scanner had higher signal attributable to larger voxel size, the analysis showed similar errors for GE data.
These
results illustrate the considerable sensitivity of linear combination modeling to imperfect basis information. Systematic errors
introduced with the use of inappropriate prior knowledge can largely outweigh
Cramér-Rao lower bounds
(CRLB)10 commonly used as
statistical confidence metrics and thereby dominate the overall error of the
MRS quantification.Conclusion
Basis
sets that do not use the experimentally realistic shaped RF pulses and timings,
or that employ the hard-pulse approximation, can appear to produce adequate
quality fits. However, the resulting metabolite levels can be substantially affected.
Basis sets should be produced via simulations that match actual experimental conditions
as closely as possible. Our results furthermore raise concerns about the validity of other commonly employed model assumptions and neglected error sources such as imperfect chemical shifts, J-couplings, and relaxation effects.Acknowledgements
No acknowledgement found.References
1. Bottomley PA. Spatial Localization
in NMR Spectroscopy in Vivo. Ann N Y Acad Sci 1987;508:333–348.
2.
Landheer K, Swanberg KM, Juchem C. Magnetic Resonance Spectrum Simulator
(MARSS), A Novel Software Package for Fast and Computationally Efficient Basis
Set Simulation. NMR Biomed 2019:e4129.
3.
Landheer K, Juchem C. Magnetic Resonance Spectrum Simulator - MARSS.
http://innovation.columbia.edu/technologies/CU19215_MARSS.
4.
Provencher SW. Estimation of metabolite concentrations from localizedin vivo
proton NMR spectra. Magn. Reson. Med. 1993;30:672–679 doi:
10.1002/mrm.1910300604.
5.
Plitman E, de la Fuente-Sandoval C, Reyes-Madrigal F, et al. Elevated
Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of
Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic
Resonance Spectroscopy Study With Implications for Glial Dysfunction.
Schizophr. Bull. 2016;42:415–424 doi: 10.1093/schbul/sbv118.
6.
Juchem C. INSPECTOR: Magnetic resonance spectroscopy software for optimized
data extraction. innovation.columbia.edu/technologies/cu17130_inspector.
Published 2020.
7.
Juchem C. INSPECTOR: “The New Kid on the Block.” ISMRM Virtual Study Group
Meeting - MR Spectroscopy. https://ismrm.adobeconnect.com/_a1156337412/pvzkfszv1l4s/.
Published 2017.
8.
Prinsen H, de Graaf RA, Mason GF, Pelletier D, Juchem C. Reproducibility
measurement of glutathione, GABA, and glutamate: Towards in vivo neurochemical
profiling of multiple sclerosis with MR spectroscopy at 7T. J. Magn. Reson.
Imaging 2017;45:187–198 doi: 10.1002/jmri.25356.
9.
Gajdošík M, Landheer K, Swanberg KM, Juchem C. INSPECTOR: Free Software for
Magnetic Resonance Spectroscopy Data Inspection, Processing, Simulation and
Analysis. Sci. Rep.:In revision.
10.
Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D. Cramér-Rao
bounds: an evaluation tool for quantitation. NMR Biomed. 2001;14:278–283 doi:
10.1002/nbm.701.